Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Trade Show, Webcast, Advisory

Arcus Biosciences to Participate in the Bank of America Healthcare Conference 2024


Arcus Biosciences (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, announced that its management team will participate in a fireside chat at the upcoming Bank of America Healthcare Conference in Las Vegas, NV. The fireside chat will take place on Thursday, May 16th, 2024 at 10:00am PT.

A live webcast of the fireside chat will be available by visiting the "Investors & Media" section of the Arcus Biosciences website at www.arcusbio.com. A replay will be available following the live event.

About Arcus Biosciences

Arcus Biosciences is a clinical-stage, global biopharmaceutical company developing differentiated molecules and combination medicines for people with cancer. In partnership with industry collaborators, patients and physicians around the world, Arcus is expediting the development of first- or best-in-class medicines against well-characterized biological targets and pathways and studying novel, biology-driven combinations that have the potential to help people with cancer live longer. Founded in 2015, the company has expedited the development of multiple investigational medicines into clinical studies, including new combination approaches that target TIGIT, PD-1, the adenosine axis (CD73 and dual A2a/A2b receptor), HIF-2a, CD39 and AXL. For more information about Arcus Biosciences' clinical and preclinical programs, please visit www.arcusbio.com.


These press releases may also interest you

at 07:05
Battery Ventures, a global, technology-focused investment firm, announced it has closed its take-private acquisition of field-service workflow company TrueContext, formerly known as ProntoForms. The Canadian software company was officially delisted...

at 07:05
Marti Technologies, Inc. ("Marti" or the "Company") , Türkiye's leading mobility super app, today announced that it has appointed Oguz Erkan as its new Chief Financial Officer ("CFO"), effective May 17, 2024. Oguz Erkan replaces the Company's former...

at 07:05
Precision BioSciences, Inc. , an advanced gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion, excision, and elimination, today...

at 07:05
Verdantis, a pioneering leader in AI-powered data solutions, proudly announces the appointment of Kumar Gaurav Gupta as its new Chief Executive Officer (CEO). Taking on the role of CEO he shoulders the responsibility of propelling growth, with a...

at 07:01
The enterprise software market is one of the fastest-growing segments within the IT industry. A Statista report shows that it consistently experiences over 10% year-on-year growth...

at 07:00
XORTX Therapeutics Inc. ("XORTX" or the "Company") , a late stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, announces that further to its press releases of March 11 and April 30,...



News published on and distributed by: